According to the 2016 WHO criteria,15 310/331 patients (94%) had MDS with RS, while 151/181 (83%) met the criteria for diagnosis of MDS with mutation of SF3B1, according to the 2022 WHO criteria.16 The gene discussed is SF3B1; the disease is myelodysplastic syndrome.